DIN 02497654 — JAMP ABACAVIR / LAMIVUDINE 300 MG; 600 MG
JAMP ABACAVIR / LAMIVUDINE is a tablet of Abacavir / Lamivudine marketed by JAMP PHARMA CORPORATION. The full Abacavir / Lamivudine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02497654
- Brand name
- JAMP ABACAVIR / LAMIVUDINE
- Active ingredient
- Abacavir / Lamivudine
- Strength
- 300 MG; 600 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Nucleoside reverse transcriptase inhibitor (NRTI) combination (antiretroviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Abacavir / Lamivudine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02399539 | APO-ABACAVIR-LAMIVUDINE | 600 MG; 300 MG | TABLET | APOTEX INC | DORMANT |
| 02454513 | AURO-ABACAVIR/LAMIVUDINE | 600 MG; 300 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02450682 | MYLAN-ABACAVIR/LAMIVUDINE | 600 MG; 300 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02458381 | PMS-ABACAVIR-LAMIVUDINE | 600 MG; 300 MG | TABLET | PHARMASCIENCE INC | DORMANT |
| 02416662 | TEVA-ABACAVIR/LAMIVUDINE | 300 MG; 600 MG | TABLET | TEVA CANADA LIMITED | MARKETED |